Pleural effusion as a significant prognostic factor in non-small cell lung cancer

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4743-4746

  Naito, Takashi ^a   Satoh, Hiroaki ^b   Ishikawa, Hiroichi ^a   Yamashita, Yuko T ^b   Kamma, Hiroshi ^b   Takahashi, Hideto ^b   Ohtsuka, Morio ^b   Hasegawa, Shizuo ^b  

^a TSUKUBA MEDICAL CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Non small cell lung cancer; Pleural effusion; Prognostic factor

Indexed keywords

PLATINUM DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PALLIATIVE THERAPY; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PROGNOSIS;

EID: 0031409715     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Samet JM: Epidemiology of lung cancer. Chest 103 (suppl 1): 20S-29S, 1993.
2. The World Health Organization Histological Typing of Lung Tumors. Am J Clin Pathol 77: 123-136, 1982.
3. De Angelis G, Cipri A, Flore F. Munno R UICC: TNM classification of malignant tumor. 4th. ed. Geneva, Switzerland: International Union Against Cancer, 1987.
4. UICC: TNM supplement 1993 A commentary on uniform use. Berlin, Springer-Verlag, 1993.
5. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
6. Cox DR: Regression models and life-tables. J Roy Stat Soc B 34: 187-220, 1972.
7. Feld R, Arriagada R, Ball DL, Mattson K, Sørensen JB: Prognostic factors in non-small cell lung cancer: a consensus report. Lung Cancer 7:3-5, 1991.
8. Feld R, Borges M, Giver V, Ginsberg R, Harper P, Klastersky J, Lacquet L, Paesmans M, Payne D, Rosell R, Sause W, Sculier JP, Shaw E, Sorensen JB, Splinter T, Stahel R, Bunn P: Prognostic factors in non-small cell lung cancer. Lung Cancer 11 (suppl 3): S19-S23, 1994.
9. Coen V, van Lancker M, de Neve W, Storme G: Prognostic factors in locoregional non-small cell lung cancer treated with radiotherapy. Am J Clin Oncol 28: 111-117, 1995.
10. Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K: Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res 3: 47-50, 1997.
11. Minna JD, Pass H, Glatstein E, Ihde DC: Cancer of the lung. In: Devita VT, Hellman S, Rosenberg SA(ed): Cancer: Principles and Practice of Oncology. Philadelphia, Lippincott, 1989, p591.
12. Hauseheer FH, Yarbro JW: Diagnosis and treatment of malignant pleural effusion. Semin Oncol 12: 54-75, 1985.
13. Ruckdeschel JC: Management of malignant pleural effusion;An overview. Semin Oncol 15: 24-28, 1988.
14. Ruckdeschel JC: Management of malignant pleural effusions. Semin Oncol 22 (suppl 3): 58-63, 1995.
15. Anderson CB, Philpott GW. Ferguson TB: The treatment of malignant pleural effusion. Cancer 33: 916-922, 1974.
16. Lambert CJ, Shah HH. Urshel HC, Paulson DL: The treatment of malignant pleural effusions by closed trocar tube drainage. Ann Thorac Surg 3: 1-5, 1967.
17. Austin EH, Flye MW: The treatment of recurrent malignant pleural effusion. Ann Thorac Surg 28: 190-203, 1979.
18. Ihde DC, Makuch RW, Carney DN, Bunn PA, Cohen MH, Matthews MJ, Minna JD: Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am Rev Respir Dis 123: 500-507, 1981.
19. O'Connell JP, Kris MG, Gralla RJ, Groshen S, Trust A, Fiore JJ, Kelsen DP, Heelan RT, Golbey RB: Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. J Clin Oncol 4: 1604-1614, 1986.
20. Shinkai T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Kojima A, Oshita F, Miya T, Okamoto H, Iemura K, Saijo N: A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy. Cancer Chemother Pharmacol 30: 1-6, 1992.